RecallRadar

FDA Device recall Z-2388-2023

MAHURKAR 12 Fr Triple Lumen Acute Dialysis Catheter, 20 cm, Curved Extensions, Kit" REF: 8888345629

On 2023-08-23 the FDA classified a Class I recall of MAHURKAR 12 Fr Triple Lumen Acute Dialysis Catheter, 20 cm, Curved Extensions, Kit" REF: 8888345629 by Covidien, citing catheter center lumen was found to have an occlusion in the tip of the catheter; the source of the occlusion an excessive MDX, a silicone-based lubricant which coats the catheter….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2388-2023
ClassificationClass I
Statusongoing
Initiated2023-06-28
Published2023-08-23
Last updated2026-09-13 11:56 UTC
CompanyCovidien
DistributionUS

Product

MAHURKAR 12 Fr Triple Lumen Acute Dialysis Catheter, 20 cm, Curved Extensions, Kit" REF: 8888345629

Reason

Catheter center lumen was found to have an occlusion in the tip of the catheter; the source of the occlusion an excessive MDX, a silicone-based lubricant which coats the catheter tip. An occluded, partially or fully, and/or uncured or excessive MDX may dislodge from the catheter lead to full catheter obstruction resulting in delay to treatment and partial obstruction resulting in reduced flow, or particulate dislodgement that may result in delay to treatment, hemolysis, embolism/embolus or thrombosis/thrombus

Identifiers

code_info
GTIN: 10884521006799 LOT Numbers: 2009400128 2113300290 2116500142 2116500176 2119400221 2119400227 2122900119 2122900…GTIN: 10884521006799 LOT Numbers: 2009400128 2113300290 2116500142 2116500176 2119400221 2119400227 2122900119 2122900127 2122900216 2122900231 2127300111 2127300113

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2388-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.